Insiders · Profile

Thunen Shelley B

See remarks at RxSight. Filing since 15 Dec 2023. CIK 0001297491

Company
Date
Role
Action
Shares
Amount
Of holding
1 Oct 2024
See remarks
Sold on a plan
15,000
$726.73K
33.0%
1 Jul 2024
Chief Financial Officer
Sold on a plan
10,000
$586.06K
41.8%
1 Jul 2024
Chief Financial Officer
Sold on a plan
8,402
$493.76K
100%
1 May 2024
Chief Financial Officer
Sold on a plan
10,000
$526.91K
41.8%
1 Apr 2024
Chief Financial Officer
Sold on a plan
20,000
$997.95K
70.4%
1 Mar 2024
Chief Financial Officer
Sold on a plan
10,000
$563.73K
42.2%
6 Feb 2024
Chief Financial Officer
Sold at will
15,875
$753.57K
53.7%
5 Feb 2024
Chief Financial Officer
Sold at will
9,125
$429.09K
40.0%
26 Jan 2024
Chief Financial Officer
Sold at will
31,772
$1.50M
82.4%
2 Jan 2024
Chief Financial Officer
Sold on a plan
10,000
$392.41K
81.4%
15 Dec 2023
Chief Financial Officer
Sold on a plan
20,000
$786.98K
89.7%
15 Dec 2023
Chief Financial Officer
Sold on a plan
20,000
$786.33K
41.3%
12 decisions on file.